Phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver.
AUTOR(ES)
Quebbeman, E J
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1250454Documentos Relacionados
- Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
- Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.
- Repeat hepatic surgery for colorectal cancer metastasis to the liver.
- Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases
- Repeat hepatectomy for colorectal liver metastases.